Revolution Farms

Mar 10, 2022
FDA won’t conduct broad sampling of leafy greens in Salinas Valley in 2022

The U.S. Food and Drug Administration (FDA) has decided to not conduct broad sampling of leafy greens grown in the Salinas Valley based on data from Western Growers (WG), the California Leafy Greens Marketing Agreement, and the California Department of Food and Agriculture inspection activities.

The FDA encouraged the organizations to continue to work with the agency to enhance the sharing of industry information on preharvest and postharvest testing as all parties aim to assure the safety of leafy greens.

“Western Growers is committed to developing and deploying data collection and analytic digital tools to further enhance the sharing of industry information,” De Ann Davis, WG’s senior vice president of science, said in a news release. “We think this is an encouraging development for our members as we strive to grow the safest produce possible.”

The FDA notes it is considering risk-based surveillance sampling based on historical data and information from previous outbreaks of foodborne illness and reserves the right to reassess this approach if unforeseen events occur.

Current Issue

VGN April Cover

Insect Eavesdropper allows growers to “hear” what’s happening in fields

Managing wildlife on the farm

Southwest Florida’s Worden Farm manages challenges

Pennsylvania Vegetable Growers Association says farewell to leader

Southeast Regional Show recognizes leaders

Veg Connections: Biopesticides and beneficial insects

Business: Why do most succession plans fail?

60 years of advocating for agricultural employers

Keeping CSA members engaged and loyal

see all current issue »

Be sure to check out our other specialty agriculture brands

produceprocessingsm Organic Grower